Logo image of MCS

MARCUS CORPORATION (MCS) Stock Fundamental Analysis

NYSE:MCS - New York Stock Exchange, Inc. - US5663301068 - Common Stock - Currency: USD

17.06  +0.14 (+0.83%)

After market: 17.06 0 (0%)

Fundamental Rating

3

Overall MCS gets a fundamental rating of 3 out of 10. We evaluated MCS against 71 industry peers in the Entertainment industry. MCS has a bad profitability rating. Also its financial health evaluation is rather negative. MCS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MCS has reported negative net income.
In the past year MCS had a positive cash flow from operations.
MCS had negative earnings in 4 of the past 5 years.
Of the past 5 years MCS 4 years had a positive operating cash flow.
MCS Yearly Net Income VS EBIT VS OCF VS FCFMCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

MCS has a better Return On Assets (-1.25%) than 61.97% of its industry peers.
MCS has a Return On Equity of -2.88%. This is in the better half of the industry: MCS outperforms 64.79% of its industry peers.
With a decent Return On Invested Capital value of 1.39%, MCS is doing good in the industry, outperforming 63.38% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MCS is significantly below the industry average of 23.28%.
Industry RankSector Rank
ROA -1.25%
ROE -2.88%
ROIC 1.39%
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
MCS Yearly ROA, ROE, ROICMCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

MCS has a better Operating Margin (2.39%) than 64.79% of its industry peers.
MCS's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 38.67%, MCS is not doing good in the industry: 61.97% of the companies in the same industry are doing better.
MCS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.39%
PM (TTM) N/A
GM 38.67%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
MCS Yearly Profit, Operating, Gross MarginsMCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MCS is destroying value.
MCS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MCS has been increased compared to 5 years ago.
MCS has a better debt/assets ratio than last year.
MCS Yearly Shares OutstandingMCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MCS Yearly Total Debt VS Total AssetsMCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MCS has an Altman-Z score of 1.59. This is a bad value and indicates that MCS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.59, MCS is in the better half of the industry, outperforming 60.56% of the companies in the same industry.
MCS has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.45, MCS is in line with its industry, outperforming 49.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.59
ROIC/WACC0.18
WACC7.8%
MCS Yearly LT Debt VS Equity VS FCFMCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MCS has a Current Ratio of 0.42. This is a bad value and indicates that MCS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.42, MCS is doing worse than 84.51% of the companies in the same industry.
MCS has a Quick Ratio of 0.42. This is a bad value and indicates that MCS is not financially healthy enough and could expect problems in meeting its short term obligations.
MCS has a worse Quick ratio (0.42) than 83.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
MCS Yearly Current Assets VS Current LiabilitesMCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The earnings per share for MCS have decreased strongly by -282.61% in the last year.
MCS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.18%.
The Revenue has been decreasing by -2.17% on average over the past years.
EPS 1Y (TTM)-282.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.11%
Revenue 1Y (TTM)4.18%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%7.38%

3.2 Future

MCS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 69.10% yearly.
MCS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y286.46%
EPS Next 2Y114.99%
EPS Next 3Y69.1%
EPS Next 5YN/A
Revenue Next Year6.85%
Revenue Next 2Y5.43%
Revenue Next 3Y4.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCS Yearly Revenue VS EstimatesMCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MCS Yearly EPS VS EstimatesMCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MCS. In the last year negative earnings were reported.
MCS is valuated quite expensively with a Price/Forward Earnings ratio of 25.02.
71.83% of the companies in the same industry are more expensive than MCS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.76. MCS is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 25.02
MCS Price Earnings VS Forward Price EarningsMCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MCS is valued cheaper than 83.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.37
MCS Per share dataMCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MCS's earnings are expected to grow with 69.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.99%
EPS Next 3Y69.1%

3

5. Dividend

5.1 Amount

MCS has a Yearly Dividend Yield of 1.69%.
MCS's Dividend Yield is rather good when compared to the industry average which is at 6.61. MCS pays more dividend than 87.32% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.39, MCS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.69%

5.2 History

The dividend of MCS decreases each year by -13.79%.
MCS has paid a dividend for at least 10 years, which is a reliable track record.
MCS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-13.79%
Div Incr Years2
Div Non Decr Years2
MCS Yearly Dividends per shareMCS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

MCS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-68.74%
EPS Next 2Y114.99%
EPS Next 3Y69.1%
MCS Yearly Income VS Free CF VS DividendMCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

MARCUS CORPORATION

NYSE:MCS (5/23/2025, 8:34:17 PM)

After market: 17.06 0 (0%)

17.06

+0.14 (+0.83%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners79.91%
Inst Owner Change-1.11%
Ins Owners5.57%
Ins Owner Change6.95%
Market Cap533.98M
Analysts82.86
Price Target26.18 (53.46%)
Short Float %2.97%
Short Ratio3.28
Dividend
Industry RankSector Rank
Dividend Yield 1.69%
Yearly Dividend0.28
Dividend Growth(5Y)-13.79%
DP-68.74%
Div Incr Years2
Div Non Decr Years2
Ex-Date05-27 2025-05-27 (0.07)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.62%
Min EPS beat(2)-73%
Max EPS beat(2)-10.24%
EPS beat(4)1
Avg EPS beat(4)-665.19%
Min EPS beat(4)-2634.65%
Max EPS beat(4)57.12%
EPS beat(8)3
Avg EPS beat(8)-322.39%
EPS beat(12)5
Avg EPS beat(12)-206.41%
EPS beat(16)8
Avg EPS beat(16)-135.95%
Revenue beat(2)2
Avg Revenue beat(2)3.59%
Min Revenue beat(2)1.88%
Max Revenue beat(2)5.29%
Revenue beat(4)4
Avg Revenue beat(4)5.54%
Min Revenue beat(4)1.88%
Max Revenue beat(4)8.6%
Revenue beat(8)7
Avg Revenue beat(8)3.58%
Revenue beat(12)11
Avg Revenue beat(12)4.64%
Revenue beat(16)15
Avg Revenue beat(16)7.84%
PT rev (1m)-2.53%
PT rev (3m)-1.28%
EPS NQ rev (1m)350%
EPS NQ rev (3m)45.16%
EPS NY rev (1m)6.67%
EPS NY rev (3m)-15.04%
Revenue NQ rev (1m)2.04%
Revenue NQ rev (3m)1.22%
Revenue NY rev (1m)1.92%
Revenue NY rev (3m)0.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.02
P/S 0.72
P/FCF N/A
P/OCF 6.38
P/B 1.21
P/tB 1.46
EV/EBITDA 8.37
EPS(TTM)-0.42
EYN/A
EPS(NY)0.68
Fwd EY4%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)2.67
OCFY15.68%
SpS23.83
BVpS14.11
TBVpS11.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.25%
ROE -2.88%
ROCE 2.04%
ROIC 1.39%
ROICexc 1.41%
ROICexgc 1.55%
OM 2.39%
PM (TTM) N/A
GM 38.67%
FCFM N/A
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
ROICexc(3y)1.83%
ROICexc(5y)N/A
ROICexgc(3y)2.03%
ROICexgc(5y)N/A
ROCE(3y)2.54%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-14.17%
ROICexc growth 3YN/A
ROICexc growth 5Y-14.65%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 2.27
Cap/Depr 124.35%
Cap/Sales 11.64%
Interest Coverage 2.14
Cash Conversion 95.52%
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z 1.59
F-Score4
WACC7.8%
ROIC/WACC0.18
Cap/Depr(3y)76.34%
Cap/Depr(5y)56.25%
Cap/Sales(3y)7.17%
Cap/Sales(5y)6.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-282.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.11%
EPS Next Y286.46%
EPS Next 2Y114.99%
EPS Next 3Y69.1%
EPS Next 5YN/A
Revenue 1Y (TTM)4.18%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%7.38%
Revenue Next Year6.85%
Revenue Next 2Y5.43%
Revenue Next 3Y4.05%
Revenue Next 5YN/A
EBIT growth 1Y-34.6%
EBIT growth 3YN/A
EBIT growth 5Y-20.28%
EBIT Next Year325.97%
EBIT Next 3Y68.8%
EBIT Next 5YN/A
FCF growth 1Y-107.68%
FCF growth 3Y-5.39%
FCF growth 5Y-20.4%
OCF growth 1Y5.96%
OCF growth 3Y30.94%
OCF growth 5Y-5.98%